Table 1.

YTHDF2 rs3738067 A>G polymorphism and neuroblastoma susceptibility.

Genotype	Cases (%) (N = 896)	Controls (%) (N = 1,733)	P a	Crude OR (95% CI)	P	Adjusted OR (95% CI)b	P b
rs3738067 (HWE=0.359)
AA	535 (59.71)	944 (54.47)		1.00		1.00
AG	292 (32.59)	680 (39.24)		0.76 (0.64–0.90)	0.002	0.76 (0.64–0.90)	0.002
GG	69 (7.70)	109 (6.29)		1.12 (0.81–1.54)	0.498	1.12 (0.82–1.55)	0.478
Additive			0.134	0.91 (0.79–1.03)	0.134	0.91 (0.80–1.03)	0.143
Dominant	361 (40.29)	789 (45.53)	0.010	0.81 (0.69–0.95)	0.010	0.81 (0.69–0.95)	0.011
Recessive	827 (92.30)	1,624 (93.71)	0.172	1.24 (0.91–1.70)	0.173	1.25 (0.91–1.71)	0.165

OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium.

Values were in bold if the P-values <0.05 or the 95% CIs excluded 1.

^aχ² test for genotype distributions between neuroblastoma cases and cancer-free controls.

^bAdjusted for age and gender.